pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

14,106 catalysts · 3,350 8k filing · 2,402 grant · 2,299 approval · 1,631 device 510k · 1,179 device recall · 1,115 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-10-08×clear all
type
  • 8k filing3,350
  • grant2,402
  • approval2,299
  • device 510k1,631
  • device recall1,179
  • device pma1,115
device adverse event
1,000
  • earnings584
  • recall465
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Oct 20, 2025

    50
    ›Oct 21, 2025approval299d agoSPEVIGO (SPESOLIMAB-SBZO) — FDA approvalspesolimab

    Sponsor: BOEHRINGER INGELHEIM PHARMACEUTICALS INC. Form: INJECTABLE. Route: INTRAVENOUS

    full page →spesolimab →fda approvals ↗
    ›Oct 21, 2025approval299d agoIMBRUVICA (IBRUTINIB) — FDA approvalAbbVie Inc.

    Sponsor: PHARMACYCLICS LLC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 21, 2025approval299d agoBLINCYTO (BLINATUMOMAB) — FDA approvalblinatumomab

    Sponsor: AMGEN. Form: INJECTABLE. Route: INJECTION

    full page →blinatumomab →fda approvals ↗
    ›Oct 21, 2025approval299d agoIMBRUVICA (IBRUTINIB) — FDA approvalAbbVie Inc.

    Sponsor: PHARMACYCLICS LLC. Form: SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Oct 21, 2025approval299d agoCELECOXIB — FDA approvalCelebrex

    Sponsor: LUPIN LTD. Form: CAPSULE. Route: ORAL

    full page →Celebrex →fda approvals ↗
    ›Oct 21, 2025approval299d agoTRIAMTERENE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalChartwell Pharmaceuticals LLC

    Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 21, 2025approval299d agoTRIAMTERENE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalChartwell Pharmaceuticals LLC

    Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 21, 2025approval299d agoCALCIUM CHLORIDE 10% (CALCIUM CHLORIDE) — FDA approvalCALCIUM CHLORIDE 10%

    Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

    full page →CALCIUM CHLORIDE 10% →fda approvals ↗
    ›Oct 21, 2025approval299d agoMIEBO (PERFLUOROHEXYLOCTANE) — FDA approvalBausch & Lomb Corp

    Sponsor: BAUSCH AND LOMB INC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Oct 21, 2025approval299d agoIMBRUVICA (IBRUTINIB) — FDA approvalAbbVie Inc.

    Sponsor: PHARMACYCLICS LLC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 21, 2025approval299d agoSUMATRIPTAN SUCCINATE — FDA approvalTonix Pharmaceuticals Holding Corp.

    Sponsor: PH HEALTH. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Oct 21, 2025approval299d agoSTIMUFEND (PEGFILGRASTIM-FPGK) — FDA approvalSTIMUFEND

    Sponsor: FRESENIUS KABI USA. Form: SOLUTION. Route: INJECTION

    full page →STIMUFEND →fda approvals ↗
    ›Oct 21, 2025approval299d agoDEFERASIROX — FDA approvalDEFERASIROX

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →DEFERASIROX →fda approvals ↗
    ›Oct 21, 2025approval299d agoDEFERASIROX — FDA approvalDEFERASIROX

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →DEFERASIROX →fda approvals ↗
    ›Oct 21, 2025approval299d agoDEFERASIROX — FDA approvalDEFERASIROX

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →DEFERASIROX →fda approvals ↗
    ›Oct 21, 2025approval299d agoDEFERASIROX — FDA approvalDEFERASIROX

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →DEFERASIROX →fda approvals ↗
    ›Oct 21, 2025approval299d agoDEFERASIROX — FDA approvalDEFERASIROX

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →DEFERASIROX →fda approvals ↗
    ›Oct 21, 2025approval299d agoDEFERASIROX — FDA approvalDEFERASIROX

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →DEFERASIROX →fda approvals ↗
    ›Oct 21, 2025device 510k299d agoOlympus Medical Systems Corporation — Disposable Balloon Catheter (B5-2Q); Disposable Balloon Catheter (B7-2Q); Disposable Balloon Catheter (B7-2LA) (510k cleared)

    Product code: FGE. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 21, 2025device 510k299d agoMIPM Mammendorfer Institut für Physik und Medizin GmbH — Neuromuscular Transmission Monitor TOF3D (2510091) (510k cleared)

    Product code: KOI. Advisory committee: Anesthesiology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 21, 2025device 510k299d agoAstura Medical — OLYMPIC Posterior Spinal Fixation System; MASADA Modular Spinal Fixation System (510k cleared)

    Product code: NKB. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 21, 2025device 510k299d agoSimplivia Healthcare , Ltd. — Chemfort® 28-day 20 mm Vial Adaptor and 13 mm Convertor (510k cleared)

    Product code: ONB. Advisory committee: General Hospital. Type: Special

    full page →fda device 510k ↗
    ›Oct 21, 2025device 510k299d agoMedivis, Inc. — NeuroAlign software (510k cleared)

    Product code: HAW. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 21, 2025device 510k299d agoMedos International SARL — TriALTIS™ Spine System (510k cleared)

    Product code: NKB. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Oct 21, 2025device 510k299d agoEdwards Lifesciences — HemoSphere Stream Module (510k cleared)Edwards Lifesciences Corp

    Product code: DQK. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Oct 21, 2025device 510k299d agoBodycad Laboratories, Inc. — Fine TTO™ (510k cleared)Barr Laboratories Inc

    Product code: PBF. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 21, 2025device 510k299d agoAevumed, Inc. — Aevumed FASE Suture Anchor (510k cleared)

    Product code: MBI. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Oct 21, 2025device 510k299d agoCardiocycle Medical(Suzhou) Co., Ltd. — Introducer Sheath Set (510k cleared)

    Product code: DYB. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 21, 2025device 510k299d agoLivsmed, Inc. — ArtiSeal Vessel Sealing System - ArtiSeal Instruments (AS01M) (510k cleared)

    Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 21, 2025device pma299d agoCordis US Corporation — PRECISE® PRO Rx Nitinol Stent System; PRECISE® PRO Transcarotid Stent System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NIM. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 21, 2025device pma299d agoMedtronic Neuromodulation — Altaviva™ Implantable Neurostimulator (PMA supplement)

    Supplement type: 30-Day Notice. Product code: QPT. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Oct 21, 2025device pma299d agoBiotronik, Inc. — Astron Peripheral Self- Expanding Nitinol Stent System (PMA supplement)

    Supplement type: Special (Immediate Track). Product code: NIO. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Oct 21, 2025device pma299d agoBiotronik, Inc. — Pulsar-18 T3 Stent System (PMA supplement)

    Supplement type: Special (Immediate Track). Product code: NIP. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Oct 21, 2025device pma299d agoInspire Medical Systems — Inspire Upper Airway Stimulation (PMA supplement)Inspire Medical Systems, Inc.

    Supplement type: 30-Day Notice. Product code: MNQ. Advisory committee: AN. Decision: OK30

    full page →fda device pma ↗
    ›Oct 21, 2025device recall299d agoAccriva Diagnostics, Inc. device recall (Cls III)Co-Diagnostics, Inc.

    VerifyNow PRUTest Platelet Reactivity Test REF 85225 UDI-DI code: 10711234150078 The VerifyNow PRUTest is a whole blood test used in the laboratory or point of care setting to measure the level of platelet P2Y12 receptor blockade. — Reason: Due to an device without a premarket clearance being incorrectly package and distributed. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 21, 2025device recall299d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    CareLink Clinic, REF: MMT-7350 — Reason: Software error causing incorrect data to be displayed on the 24-hour Sensor Glucose Overview Graph, any potential therapy decisions were made based on the incorrect data displayed on the 24-hour sensor glucose overview graph may lead to hypoglycemia or hyperglycemia. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025approval298d agoSIMPONI (GOLIMUMAB) — FDA approvalJanssen Biotech Inc

    Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Oct 22, 2025approval298d agoNICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE (NICARDIPINE HYDROCHLORIDE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: CAPLIN. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Oct 22, 2025approval298d agoESMOLOL HYDROCHLORIDE — FDA approvalESMOLOL HYDROCHLORIDE

    Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

    full page →ESMOLOL HYDROCHLORIDE →fda approvals ↗
    ›Oct 22, 2025approval298d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: L PERRIGO CO. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Oct 22, 2025approval298d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: L PERRIGO CO. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Oct 22, 2025approval298d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: L PERRIGO CO. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Oct 22, 2025approval298d agoOXALIPLATIN — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Oct 22, 2025approval298d agoCONTEPO (FOSFOMYCIN DISODIUM) — FDA approvalfosfomycin disodium

    Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS

    full page →fosfomycin disodium →fda approvals ↗
    ›Oct 22, 2025approval298d agoVYEPTI (EPTINEZUMAB-JJMR) — FDA approvalH. Lundbeck AS

    Sponsor: Lundbeck Seattle BioPharmaceuticals, Inc.. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Oct 22, 2025approval298d agoVISINE (NAPHAZOLINE HYDROCHLORIDE) — FDA approval

    Sponsor: KENVUE BRANDS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Oct 22, 2025approval298d agoLOFEXIDINE HYDROCHLORIDE — FDA approvalLOFEXIDINE HYDROCHLORIDE

    Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

    full page →LOFEXIDINE HYDROCHLORIDE →fda approvals ↗
    ›Oct 22, 2025approval298d agoARIPIPRAZOLE — FDA approvalaripiprazole LA

    Sponsor: QUAGEN. Form: SOLUTION. Route: ORAL

    full page →aripiprazole LA →fda approvals ↗
    ›Oct 22, 2025recall298d agoAscend Laboratories, LLC recall (Cls II)Ascend Laboratories Ltd

    Atorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDC 67877-514-05), Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054 — Reason: Failed Dissolution Specifications — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 22, 2025recall298d agoRising Pharma Holding, Inc. recall (Cls II)CHINA PHARMA HOLDINGS, INC.

    Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01 — Reason: Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg). — Status: Ongoing

    full page →fda recalls ↗
    ← prev
    page 10 of 283
    next →
    $ABBV249.46-0.54%
    $AMGN415.21-0.63%
    $ABBV249.46-0.54%
    $AMRX18.15+5.10%
    $BLCO17.05+0.41%
    $ABBV249.46-0.54%
    $INSP42.44+0.38%
    $EW91.33-2.47%
    $TNXP12.71+1.68%
    $CODX1.51000.00%
    $AMRX18.15+5.10%
    $CPHI0.7101-0.82%
    $PRGO13.04+1.64%
    $PRGO13.04+1.64%
    $PRGO13.04+1.64%